Therapeutic Asset Ratings
766 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
177lu-dfc413
Pancreatic Ductal Adenocarcinoma
Novartis Pharmaceuticals
P1
C
(37)
177lu-dfc413
Triple-Negative Breast Carcinoma
Novartis Pharmaceuticals
P1
C
(37)
[177lu]lu-evs459
Lung Cancer
Novartis Pharmaceuticals
P1
C
(37)
[177lu]lu-nns309
Pancreatic Ductal Adenocarcinoma
Novartis Pharmaceuticals
P1
C
(37)
[177lu]lu-nns309
Triple-Negative Breast Carcinoma
Novartis Pharmaceuticals
P1
C
(37)
[ 18f]3f4ap
Alzheimer Disease
Yale University
P1
C
(37)
[18f]pt2385
Renal Cell Carcinoma
Orhan Kemal Oz
P1
C
(37)
18f-αvβ6-bp
Lung Cancer
University of California, Davis
P1
C
(37)
18f-αvβ6-bp
Non-Small Cell Lung Carcinoma
University of California, Davis
P1
C
(37)
²¹²pb-dotam-grpr1
Cervical Cancer
Orano Med Theranostics, SAS
P1
C
(37)
²¹²pb-dotam-grpr1
Colon Carcinoma
Orano Med Theranostics, SAS
P1
C
(37)
²¹²pb-dotam-grpr1
Glioblastoma
Orano Med Theranostics, SAS
P1
C
(37)
²¹²pb-dotam-grpr1
Non-Small Cell Lung Carcinoma
Orano Med Theranostics, SAS
P1
C
(37)
[225Ac]Ac-AKY-1189
Non-Small Cell Lung Carcinoma
Aktis Oncology, Inc.
P1
C
(37)
[225ac]ac-fl-020
Metastatic Prostate Carcinoma
Full-Life Technologies UK Limited
P1
C
(37)
[225]-fpi-2059
Gastric Cancer
3B Pharmaceuticals GmbH
P1
C
(37)
[68ga]ga-dwj155
Breast Neoplasm
Novartis Pharmaceuticals
P1
C
(37)
[68ga]ga-dwj155
Non-Small Cell Lung Carcinoma
Novartis Pharmaceuticals
P1
C
(37)
[68ga]ga-evs459
Lung Cancer
Novartis Pharmaceuticals
P1
C
(37)
azd2284
Metastatic Prostate Carcinoma
AstraZeneca
P1
C
(37)
bay3546828
Metastatic Prostate Carcinoma
Bayer
P1
C
(37)
Indium In 111-Dota-Basiliximab
Acute Lymphoblastic Leukemia
City of Hope Medical Center
P1
C
(37)
Indium In 111-Dota-Daratumumab
Acute Lymphoblastic Leukemia
City of Hope Medical Center
P1
C
(37)
[Lu-177]-Pnt6555
Esophageal Cancer
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company
P1
C
(37)
[Lu-177]-Pnt6555
Head And Neck Squamous Cell Carcinoma
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company
P1
C
(37)
Showing 526 to 550 of 766 assets
Previous
Page 22 of 31
Next